The Gross Margin of Balaxi Pharmaceuticals Ltd (BALAXI.NS) is 46.67%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 46.67% |
| 2023-03-31 | 39.75% |
| 2022-03-31 | 29.99% |
| 2021-03-31 | 25.58% |
| 2020-03-31 | 28.01% |
| 2019-03-31 | 23.01% |